CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fulgent Genetics (FLGT – Research Report), Alignment ...
In an extraordinary achievement of advanced multiplexed genome engineering, Colossal Biosciences announces the birth of the Colossal Woolly Mouse?mice engineered to express multiple key mammoth-like ...
Twist Bioscience Co. (NASDAQ:TWST) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, Ratings reports. One investment ...
Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercodetm single cell chromatin ...
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, ...
DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...
The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results